Furthermore, subgroup analyses according to tumor resectability and the treatment and detection methods of K-ras still revealed that K-ras gene mutations were strongly correlated with poorer prognoses in patients with pancreatic cancer. The gene discussed is KRAS; the disease is neoplasm.